Skip to main content
Date Issued
Submitting OIG
Department of Health & Human Services OIG
Other Participating OIGs
Department of Health & Human Services OIG
Agencies Reviewed/Investigated
Department of Health & Human Services
Report Number
OEI-02-20-00390
Report Type
Inspection / Evaluation
Agency Wide
Yes
Number of Recommendations
6
Questioned Costs
$0
Funds for Better Use
$0
Report updated under NDAA 5274
No

Open Recommendations

This report has 6 open recommendations.
Recommendation Number Significant Recommendation Recommended Questioned Costs Recommended Funds for Better Use Additional Details
7022 No $0 $0

CMS should conduct additional outreach to beneficiaries to increase awareness about Medicare coverage for the treatment of opioid use disorder.

7023 No $0 $0

CMS should take steps to increase the number of providers and opioid treatment programs for Medicare beneficiaries with opioid use disorder.

7024 No $0 $0

CMS should assist SAMHSA by providing data about the number of Medicare beneficiaries receiving buprenorphine in office-based settings and the geographic areas where Medicare beneficiaries remain underserved.

7025 No $0 $0

CMS should take steps to increase the utilization of behavioral therapy among beneficiaries receiving medication to treat opioid use disorder.

7026 No $0 $0

CMS should create an action plan and take steps to address disparities in the treatment of opioid use disorder.

7027 No $0 $0

CMS should collect data on the use of telehealth in opioid treatment programs.

Department of Health & Human Services OIG

United States